Discover the uses of serum calprotectin in adult and pediatric patients suffering from autoinflammatory diseases.
Understand the clinical and laboratory aspects that affect serum FLC testing in diagnosis and monitoring of monoclonal gammopathies.
Understand more about the role of biomarkers in inflammatory disease in the central nervous system (kappaFLC & sNFL).
Serum free light chains testing in monoclonal gammopathies
Learn about the clinical and laboratory aspects impacting serum free light chains testing in diagnosis and monitoring of monoclonal gammopathies.
Excluding intrathecal inflammation using the kFLC index in CSF
Understand the concept of excluding intrathecal inflammation by measuring kappa free light chain (kFLC) in CSF and serum and hear the results of a prospective multicenter validation study of this new laboratory workflow that integrates the free light chains kappa quotient in CSF analysis.
Diagnosis and management of MGRS
Learn about the significance of monoclonal gammopathy of renal significance (MGRS), including diagnosis and management of the disease.
Diagnosis and management of IgG4-related disease
Learn about IgG4-related disease, including how the disease is diagnosed and managed in clinics and laboratories.
Serum amyloid A as an early predictor of severity in COVID-19
Learn about Serum amyloid A (SAA) and its utility in COVID-19 disease management.
Diagnosis of kidney dysfunction
Learn more about kidney dysfunction diagnosis, including recent recommendations on the calculation of estimated glomerular filtration rate (eGFR).
FLC testing in multiple myeloma and kidney disease: An American Perspective
Learn about free light chain (FLC) testing in multiple myeloma and the influence of kidney function on FLC test results.
FLC testing in multiple myeloma and kidney disease: A Chinese Perspective
Learn about FLC testing in multiple myeloma and the influence of kidney function on FLC test results.
FLC testing in the diagnosis and monitoring of AL amyloidosis
Learn about free light chain (FLC) testing in the detection and monitoring of amyloidosis.
The importance of FLC testing in MGUS patients
Understand the key role of free light chain (FLC) testing in the detection and monitoring of MGUS.
kFLC in CSF as a diagnostic marker for multiple sclerosis
Learn about the role of the kappa free light chain index in cerebrospinal fluid for diagnosis and management of multiple sclerosis.
Learn about the value of serum amyloid A (SAA) and other inflammation markers in the management of hospitalized COVID-19 patients.
Subscribe to news from Siemens Healthineers UK and Ireland
Keep up to date on the latest trends in healthcare. Read about current developments, new products and upcoming events.